We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Cells Harvested From Urine to Enable Earlier Kidney Disease Detection

By LabMedica International staff writers
Posted on 20 Mar 2024
Print article
Image: Cells harvested from urine offers potential for non-invasive diagnostic testing of kidney disease (Photo courtesy of 123RF)
Image: Cells harvested from urine offers potential for non-invasive diagnostic testing of kidney disease (Photo courtesy of 123RF)

Detecting kidney disease late can lead to severe and even life-threatening issues. Now, new research has found that the genes expressed in human cells harvested from urine closely match those in the kidney, suggesting that these cells could offer a non-invasive approach to better understanding kidney health. This discovery could allow the diagnosis of kidney problems without doing biopsies, making it possible to detect kidney disease earlier and more easily.

A team of scientists led by the University of Manchester (Manchester, UK) used a method called transcriptomics to measure the levels of about 20,000 genes in each cellular sediment sample of urine. Transcriptomics helps scientists see which genes are active or inactive, providing insights into how cells adapt to changes in their environment. This molecular-level understanding can lead to more accurate diagnoses and better patient outcomes. The team also had access to the world's largest collection of human kidney samples from surgeries or biopsies, known as the Human Kidney Tissue Resource, at the University of Manchester.

The researchers used advanced computational methods to extract both DNA and RNA from the samples and analyze data from previous large-scale studies on blood pressure. They discovered that a low level of a particular gene in the kidney could be a cause of high blood pressure. This gene, ENPEP, produces an enzyme called aminopeptidase and is crucial for blood pressure regulation. It was among the 399 genes identified in the study whose levels in the kidney have a direct impact on blood pressure readings.

“This study shows that using cutting edge technology we are able to combine different unique datasets together using genetics as a connector,” said Professor Maciej Tomaszewski, Chair of Cardiovascular Medicine at The University of Manchester, who led the study. “One of the most exciting findings of that is we discover how cells harvested from urine have the potential to provide a glimpse into the molecular operation of the human kidney. That gives us an exciting avenue of research for non-invasive diagnostic testing.”

“There is a well-known link between the heart and the kidneys in regulating blood pressure,” said Professor Bryan Williams, Chief Scientific and Medical Officer at the British Heart Foundation which funded the study. “This study uses cutting-edge scientific techniques to analyze genes present in kidney cells that are normally expelled in the urine. Analyzing these cells could reveal which genes may be playing a key role in people with high blood pressure, and could potentially offer clinicians a new, non-invasive way to help diagnose those with kidney disease early on.”

Related Links:
University of Manchester

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.